Welcome back, DERM Community.

Last issue we looked at patients who say they're allergic to the sun. This week we move down to the legs, to a finding so common that most of us stopped seeing it.

By the numbers

  • 59% of a random adult sample aged 18 to 79 had telangiectasias or reticular veins as their only venous sign (CEAP C1).

  • 9.6% of that same sample had no venous signs at all.

  • 41% of women over 50 have leg spider veins.

Those numbers explain why spider veins get a shrug in clinic. They also hide a smaller group of patients whose spider veins:

  • sit on top of saphenous reflux,

  • cluster at the ankle as an early marker of advanced disease, or

  • are not venous at all.

Patients usually ask for one of two reasons: they don't like how their legs look, or their legs ache, burn or itch.

Mistake 1: Calling every spider vein cosmetic without looking at the ankle

Bottom line: spider veins on the thigh are C1. The same veins clustered below the medial malleolus are C4c, and that patient needs a venous workup.

The evidence

  • Size defines the class. Telangiectasias are under 1 mm and reticular veins under 3 mm. Both are CEAP C1.

  • C4c is new. The 2020 CEAP update added C4c for corona phlebectatica: a fan of blue telangiectatic and reticular veins around the medial malleolus.

  • Why C4 and not C1: corona phlebectatica signals reflux, usually in the great saphenous vein, and is a risk factor for venous ulceration.

  • Symptoms are real for some patients. Cochrane describes leg spider veins as sometimes purely cosmetic and sometimes a source of pain, burning or itching.

  • Edinburgh Vein Study: 51% of people with moderate to severe telangiectasia had no clinical varicose veins. Symptoms were most frequent in people who had both. This is an association, not proof that spider veins cause symptoms.

In clinic

  1. Examine the patient standing.

  2. Ask about aching, heaviness, swelling, itching and night cramps.

  3. Look specifically at the medial ankle.

Interested in reaching our 8,000+ subscribers?

Click here to learn more!

Mistake 2: Ordering a duplex for every spider vein, or for none

Bottom line: skip the duplex for asymptomatic spider veins. Order it when specific red flags appear.

The evidence

  • Statement 1.5.1 (asymptomatic C1): duplex should not be routinely performed, because testing could lead to unnecessary saphenous ablation.

  • Statement 1.5.2 (symptomatic C1 with bleeding or severe pain or burning): duplex may be performed to exclude associated venous incompetence. Saphenous ablation for C1 disease without bleeding is rarely required.

Reflux under C1 legs is common but mostly minor:

  • Engelhorn (cited in the guideline): great saphenous reflux in 44% of limbs in women with telangiectasias.

    • 73% of that reflux was segmental.

    • Only 4% involved the saphenofemoral junction.

  • Edinburgh: worse telangiectasia was associated with more great saphenous reflux, but not consistently.

In clinic: when to order a venous duplex

When spider veins come with any of these:

  • Bleeding

  • Severe pain or burning

  • Corona phlebectatica (C4c)

  • Visible varicose veins of 3 mm or more

  • Edema

  • Skin changes

Skip it for asymptomatic spider veins alone, and tell the patient why.

Mistake 3: Assuming every telangiectasia on the leg is venous

Bottom line: venous spider veins have a typical look. When the pattern is off, rule out systemic causes before any cosmetic treatment.

Typical venous pattern: bluish to red, linear or branching, often fed by a visible reticular vein.

Patterns that point elsewhere

Spider angioma

  • Pattern: central red point with radiating legs, may pulsate

  • Look for: multiple lesions suggest liver disease (95% specificity for chronic liver disease). A single one in a healthy or pregnant patient needs no workup.

Hereditary hemorrhagic telangiectasia

  • Pattern: pinhead red macules or papules on lips, tongue, fingertips

  • Look for: recurrent nosebleeds, GI bleeding, iron deficiency anemia, family history

Systemic sclerosis

  • Pattern: matted, discrete 1 to 5 mm lesions

  • Look for: Raynaud, puffy fingers, skin tightening, periungual capillary changes

Generalized essential telangiectasia

  • Pattern: widespread lesions starting on the lower legs and spreading upward

  • Look for: nothing specific; it's a diagnosis of exclusion once systemic causes are ruled out

In clinic: three questions before calling it venous

  1. Any nosebleeds or bleeding from the gut?

  2. Any color change in the fingers in the cold?

  3. Any liver disease or heavy alcohol use?

If the pattern or answers fit, order a CBC, liver tests and an ANA with scleroderma antibodies as indicated. Refer before any cosmetic treatment.

Mistake 4: Steering patients to laser first, or promising one session

Bottom line: sclerotherapy is first line, most patients need more than one session, and new spider veins will keep forming.

What the guidelines recommend

Liquid or foam sclerotherapy: first line

  • Recommendation 7.1.1 (recommend), grade 1, moderate evidence

  • Use for: symptomatic telangiectasias and reticular veins

Transcutaneous laser: for specific cases

  • Recommendation 7.1.2 (suggest), grade 2, moderate evidence

  • Use for: sclerosant allergy, needle phobia, sclerotherapy failure, or veins under 1 mm with telangiectatic matting

What the trials show

  • Cochrane 2021 (35 trials, 3,632 participants): sclerosants improved resolution compared with sham but caused more hyperpigmentation and matting. No single treatment was established as preferable. Certainty was low.

  • EASI trial (patient satisfaction):

  • EASI trial (patient satisfaction):

    • Polidocanol: 84% satisfied at 12 weeks, 88% at 26 weeks

    • Sodium tetradecyl sulfate: 64% at 12 weeks, 63% at 26 weeks

    • Placebo: 14% at 12 weeks, 11% at 26 weeks

The EASI trial was funded by the polidocanol manufacturer.

Polidocanol (Asclera) at a glance

  • FDA-approved for uncomplicated spider veins (1 mm or less, 0.5% solution) and reticular veins (1 to 3 mm, 1% solution)

  • Up to 10 mL per session

  • Repeat sessions 1 to 2 weeks apart when needed

New veins keep forming: in one Italian series, 58.9% of treated areas showed new telangiectases at 3 years.

In clinic: three expectations to set when you refer

  1. Injections are the first-line option.

  2. Most patients need more than one session.

  3. New spider veins will likely appear over the years.

Practical reset checklist

Examine

  • Examine legs with the patient standing

  • Ask about aching, heaviness, swelling, itching, cramps and any bleeding

  • Check the medial ankle for corona phlebectatica (C4c, not C1)

Decide

  • Order duplex only for bleeding, severe symptoms, C4c, varicose veins of 3 mm or more, edema or skin changes

  • Rule out non-venous telangiectasia: spider angioma, HHT, systemic sclerosis

Refer

  • Name sclerotherapy as first line; reserve laser for allergy, needle phobia, failure or fine matting

  • Set expectations: several sessions, new veins over time

  • Screen for pregnancy, prior DVT or PE, migraine with aura or PFO, and past sclerosant reactions

  • Warn about brown streaks and matting, and the role of compression afterward

❝

"The good physician treats the disease; the great physician treats the patient who has the disease."

Widely attributed to Sir William Osler

Some Jobs We Think You’re Gonna Love:

👋🏻 Thank you for being here, DERM community!

Thank you for reading this far. Spider veins rarely make it onto anyone's list of exciting topics, and yet they show up in clinic almost every week. If this issue changes one thing, I hope it's the way you look at that side comment at the end of a visit. A standing exam and a quick look at the ankle cost very little, and they can change what happens next for the patient in front of you.

Coming up next: acne in 2026

Thank you for reading Beneath the Surface, and for the care you bring to every skin complaint that walks through your door.

Many of our topics start with questions from readers, so if there's a presentation you keep seeing in clinic and want us to cover, reply to this email and tell us!

DERM Community | Derm for Primary Care Team

Reply

Avatar

or to participate